181 related articles for article (PubMed ID: 8241324)
1. How and when do tumor cells metastasize?
Mareel MM; Van Roy FM; Bracke ME
Crit Rev Oncog; 1993; 4(5):559-94. PubMed ID: 8241324
[TBL] [Abstract][Full Text] [Related]
2. [When and why does cancer metastasize? An overview of current viewpoints OF the molecular mechanism of invasiveness].
Mareel M
Verh K Acad Geneeskd Belg; 1994; 56(2):105-25. PubMed ID: 8048267
[TBL] [Abstract][Full Text] [Related]
3. Clinical, cellular, and molecular aspects of cancer invasion.
Mareel M; Leroy A
Physiol Rev; 2003 Apr; 83(2):337-76. PubMed ID: 12663862
[TBL] [Abstract][Full Text] [Related]
4. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes.
Nicolson GL
Curr Opin Oncol; 1991 Feb; 3(1):75-92. PubMed ID: 2043698
[TBL] [Abstract][Full Text] [Related]
6. Role of integrins and other cell adhesion molecules in tumor progression and metastasis.
Albelda SM
Lab Invest; 1993 Jan; 68(1):4-17. PubMed ID: 8423675
[TBL] [Abstract][Full Text] [Related]
7. Review of Growth Inhibitory Peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis.
Muehlemann M; Miller KD; Dauphinee M; Mizejewski GJ
Cancer Metastasis Rev; 2005 Sep; 24(3):441-67. PubMed ID: 16258731
[TBL] [Abstract][Full Text] [Related]
8. Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion.
Iida J; Meijne AM; Knutson JR; Furcht LT; McCarthy JB
Semin Cancer Biol; 1996 Jun; 7(3):155-62. PubMed ID: 8773301
[TBL] [Abstract][Full Text] [Related]
9. Progress in molecular mechanisms of tumor metastasis and angiogenesis.
Harlozinska A
Anticancer Res; 2005; 25(5):3327-33. PubMed ID: 16101146
[TBL] [Abstract][Full Text] [Related]
10. Assessment of local proteolytic milieu as a factor in tumor invasiveness and metastasis formation: in vitro collagen degradation and invasion assays.
Petrella BL
Methods Mol Biol; 2009; 511():75-84. PubMed ID: 19347293
[TBL] [Abstract][Full Text] [Related]
11. Tumor invasion as dysregulated cell motility.
Kassis J; Lauffenburger DA; Turner T; Wells A
Semin Cancer Biol; 2001 Apr; 11(2):105-17. PubMed ID: 11322830
[TBL] [Abstract][Full Text] [Related]
12. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells.
Tantivejkul K; Vucenik I; Shamsuddin AM
Anticancer Res; 2003; 23(5A):3671-9. PubMed ID: 14666663
[TBL] [Abstract][Full Text] [Related]
13. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori S
Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
[TBL] [Abstract][Full Text] [Related]
14. Adhesion molecules in tumor metastasis.
Zetter BR
Semin Cancer Biol; 1993 Aug; 4(4):219-29. PubMed ID: 8400144
[TBL] [Abstract][Full Text] [Related]
15. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer.
Mareel M; Vleminckx K; Vermeulen S; Yan G; Bracke M; van Roy F
Princess Takamatsu Symp; 1994; 24():63-80. PubMed ID: 8983064
[TBL] [Abstract][Full Text] [Related]
16. The cell clone ecology hypothesis and the cell fusion model of cancer progression and metastasis (II): three pathways for spontaneous cell-cell fusion and escape from the intercellular matrix.
Parris G
Med Hypotheses; 2006; 67(1):172-6. PubMed ID: 16516400
[TBL] [Abstract][Full Text] [Related]
17. Axis of evil: molecular mechanisms of cancer metastasis.
Bogenrieder T; Herlyn M
Oncogene; 2003 Sep; 22(42):6524-36. PubMed ID: 14528277
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical roles for lysyl oxidases in cancer--a prospect.
Payne SL; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2007 Aug; 101(6):1338-54. PubMed ID: 17471532
[TBL] [Abstract][Full Text] [Related]
19. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.
Shen Y; Jia Z; Nagele RG; Ichikawa H; Goldberg GS
Cancer Res; 2006 Feb; 66(3):1543-52. PubMed ID: 16452211
[TBL] [Abstract][Full Text] [Related]
20. [Matrix metalloproteinases and colorectal cancer].
Roeb E; Matern S
Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
